Johan de Ruiter

Johan de Ruiter has many years of experience in the global medical technology and healthcare industry. Until 2007 he served on the executive board of a medium-sized company in orthopedics, diabetes and vascular surgery from the USA (Aircast LLC). Together with his colleagues he sold the company, whose main investor was Tailwind Capital Partners, to DJO Global in 2006.

Prior to that, Johan de Ruiter served as Executive Vice President Dialysis International at Fresenius AG, where he was responsible for all dialysis activities outside Germany and was the initiator and founder of Fresenius Medical Care AG with an IPO at the stock exchanges in Frankfurt and New York. He then founded a company which operates medical laboratories which is now part of Amedes Holding AG.

He is Chairman of Quanta Fluid Solutions in UK (a disruptive hemodialysis technology), founded the Auxilium group (rehabilitation, home care, orthopedics, surgical supplies), which is the largest provider in its market in Germany. b-to-v is a founding investor in both companies. Moreover, he is a non-executive board member at GNA Biosolutions (also backed by btov) and the owner of Sanitaetshaus Achim Kunze GmbH.

In 1980 Johan de Ruiter started his career with the Dade Diagnostics division of American Hospital Supply (Baxter resp. Siemens healthcare). Later he worked as European Product Manager at Abbott Diagnostics and then seven years at A. T. Kearney Management Consultants. In addition, since 2001 Johan de Ruiter is on the board of CHT Beitlich/Bezema Group (Chairman), a chemical company from Tuebingen, Germany/Montlingen, Switzerland.

He studied in the Netherlands (Nyenrode Business University) and at Michigan State University, USA (MBA in Marketing and Finance), both with honors.

Press enter or esc to cancel